U
SCR

UBS’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

UBS’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,248
Closed -$22K – 6913
2013
Q4 		$22K Buy
2,248
+999
+80% +$9.78K ﹤0.01% 5149
2013
Q3 		$12K Sell
1,249
-1,055
-46% -$10.1K ﹤0.01% 5402
2013
Q2 		$22K Buy
+2,304
New +$22K ﹤0.01% 4841